UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnosing Synucleinopathies: Will Parkinson’s Disease or Dementia with Lewy Bodies Become ‘Biologically’ Defined?

European Medical Journal. Neurology, 2024-08, p.94-97

Poewe, Werner

2024

Volltextzugriff (PDF)

Parkinson disease and the immune system - associations, mechanisms and therapeutics

Nature reviews. Neurology, 2020-06, Vol.16 (6), p.303-318

2020

Volltextzugriff (PDF)

The natural history of Parkinson's disease

Journal of neurology, 2006-12, Vol.253 Suppl 7 (S7), p.VII2-vii6

Poewe, Werner

2006

Volltextzugriff (PDF)

Clinical measures of progression in Parkinson's disease

Movement disorders, 2009, Vol.24 (S2), p.S671-S676

Poewe, Werner

2009

Volltextzugriff (PDF)

Treatments for Parkinson disease--past achievements and current clinical needs

Neurology, 2009-02, Vol.72 (7 Suppl), p.S65

Poewe, Werner

2009

Volltextzugriff (PDF)

Parkinson disease Primer - a true team effort

Nature reviews. Disease primers, 2020-04, Vol.6 (1), p.31-31, Article 31

Poewe, Werner

2020

Volltextzugriff (PDF)

MDS clinical diagnostic criteria for Parkinson's disease

Movement disorders, 2015-10, Vol.30 (12), p.1591-1601

2015

Volltextzugriff (PDF)

The Concept of Prodromal Parkinson's Disease

Journal of Parkinson's disease, 2015-10, Vol.5 (4), p.681-697

2015

Volltextzugriff (PDF)

The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy

Movement disorders, 2022-06, Vol.37 (6), p.1131-1148

2022

Volltextzugriff (PDF)

Trial of Cinpanemab in Early Parkinson’s Disease

The New England journal of medicine, 2022-08, Vol.387 (5), p.408-420

2022

Volltextzugriff (PDF)

Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease

Lancet neurology, 2007-09, Vol.6 (9), p.826-829

2007

Volltextzugriff (PDF)

Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial

Lancet neurology, 2016-02, Vol.15 (2), p.154-165

2016

Volltextzugriff (PDF)

Milestones in Parkinson's disease therapeutics

Movement disorders, 2011-05, Vol.26 (6), p.1072-1082

2011

Volltextzugriff (PDF)

Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes

Parkinsonism & related disorders, 2015-03, Vol.21 (3), p.231-235

2015

Volltextzugriff (PDF)

MDS research criteria for prodromal Parkinson's disease

Movement disorders, 2015-10, Vol.30 (12), p.1600-1611

2015

Volltextzugriff (PDF)

Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine

Movement disorders, 2018-10, Vol.33 (10), p.1528-1539

2018

Volltextzugriff (PDF)

Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease

Movement disorders, 2013-07, Vol.28 (8), p.1064-1071

2013

Volltextzugriff (PDF)

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

Movement disorders, 2011-10, Vol.26 (S3), p.S42-S80

2011

Volltextzugriff (PDF)

Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked

Parkinsonism & related disorders, 2017-07, Vol.40, p.1-10

2017

Volltextzugriff (PDF)

Smelling Parkinson’s Disease: New Metabolomic Biomarker for PD

ACS central science, 2019-04, Vol.5 (4), p.575-576

Poewe, Werner

2019

Volltextzugriff (PDF)

Validation of the freezing of gait questionnaire in patients with Parkinson's disease

Movement disorders, 2009-04, Vol.24 (5), p.655-661

2009

Volltextzugriff (PDF)

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

Movement disorders, 2011-10, Vol.26 (S3), p.S2-S41

2011

Volltextzugriff (PDF)

Validation of the MDS clinical diagnostic criteria for Parkinson's disease

Movement disorders, 2018-10, Vol.33 (10), p.1601-1608

2018

Volltextzugriff (PDF)

Dysautonomia and cognitive dysfunction in Parkinson's disease

Movement disorders, 2007, Vol.22 (S17), p.S374-S378

Poewe, Werner

2007

Volltextzugriff (PDF)

Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder

Annals of neurology, 2017-09, Vol.82 (3), p.419-428

2017

Volltextzugriff (PDF)

1 – 25 von 899

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(826)
Mit Volltextzugriff
(754)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(888)
Deutsch
(9)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Movement Disorders
(258)
Neurology
(61)
Parkinsonism & Related Disorders
(39)
Lancet Neurology
(34)
Journal Of Neurology
(24)
Movement Disorders Clinical Practice
(24)
Sleep Medicine
(22)
Sleep
(19)
European Journal Of Neurology
(14)
Journal Of Parkinson's Disease
(14)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Diagnosing Synucleinopathies: Will Parkinson’s Disease or Dementia with Lewy Bodies Become ‘Biologically’ Defined?

Parkinson disease and the immune system - associations, mechanisms and therapeutics

The natural history of Parkinson's disease

Clinical measures of progression in Parkinson's disease

Treatments for Parkinson disease--past achievements and current clinical needs

Parkinson disease Primer - a true team effort

MDS clinical diagnostic criteria for Parkinson's disease

The Concept of Prodromal Parkinson's Disease

The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy

Trial of Cinpanemab in Early Parkinson’s Disease

Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease

Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial

Milestones in Parkinson's disease therapeutics

Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes

MDS research criteria for prodromal Parkinson's disease

Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine

Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked

Smelling Parkinson’s Disease: New Metabolomic Biomarker for PD

Validation of the freezing of gait questionnaire in patients with Parkinson's disease

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

Validation of the MDS clinical diagnostic criteria for Parkinson's disease

Dysautonomia and cognitive dysfunction in Parkinson's disease

Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder

Suchergebnisse filtern